UPDATED Apr 23, 2024
All the companies in the healthcare sector, including healthcare provider and equipment, healthcare tech, pharmaceuticals, biotech and life sciences.
Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | ||
---|---|---|---|---|---|---|---|---|---|---|
EDU | US$89.59 | 6.0% | 97.6% | US$14.8b | US$98.41 | PE48.4x | E25.1% | 0% | ||
SCI | US$70.98 | 3.6% | 1.2% | US$10.4b | US$77.50 | PE19.4x | E3.2% | 1.7% | ||
GSHN | US$22.70 | 0% | -18.9% | US$9.6b | n/a | PS4529.1x | n/a | n/a | ||
DUOL | US$220.53 | 13.3% | 61.4% | US$9.5b | US$250.83 | PE588.5x | E56.8% | n/a | ||
PSON | UK£10.15 | 2.8% | 19.2% | UK£6.9b | UK£11.33 | PE18.1x | E7.6% | 2.2% | ||
TAL | US$12.19 | 4.9% | 103.8% | US$7.8b | US$13.59 | PS5.9x | E75.9% | 0% | ||
HRB | US$47.65 | 1.7% | 43.0% | US$6.6b | US$49.67 | PE11.2x | E1.3% | 2.7% | ||
BFAM | US$107.62 | 4.0% | 48.0% | US$6.2b | US$107.36 | PE84.2x | E35.9% | n/a | ||
ADT | US$6.36 | 2.9% | -3.0% | US$5.7b | US$9.37 | PS1.2x | E56.4% | 3.5% | ||
LOPE | US$128.70 | -1.6% | 11.2% | US$3.8b | US$158.33 | PE18.6x | E7.5% | n/a | ||
GHC | US$718.90 | 3.4% | 25.7% | US$3.2b | US$625.00 | PE15.7x | S5.2% | 1.0% | ||
IEL | AU$16.37 | 0.7% | -43.3% | AU$4.5b | AU$22.99 | PE27.8x | E13.8% | 2.5% | ||
LRN | US$58.20 | 1.1% | 36.2% | US$2.5b | US$71.75 | PE14.4x | E12.1% | n/a | ||
FTDR | US$31.05 | 4.9% | 18.1% | US$2.4b | US$40.20 | PE14.2x | E8.9% | n/a | ||
STRA | US$99.35 | 1.3% | 7.5% | US$2.4b | US$124.25 | PE34.7x | E30.2% | 2.4% | ||
LAUR | US$14.25 | 1.3% | 17.2% | US$2.2b | US$17.50 | PE19.1x | E20.7% | 4.9% | ||
MCW | US$7.03 | 8.3% | -16.8% | US$2.2b | US$9.63 | PE27.9x | E18.7% | n/a | ||
ROVR | US$10.99 | 0.2% | 155.0% | US$2.0b | US$10.40 | PE183.9x | E34.4% | n/a | ||
PLWN | US$572.50 | 0% | n/a | US$2.0b | n/a | n/a | n/a | n/a | ||
COUR | US$12.12 | 2.5% | 18.7% | US$1.9b | US$23.02 | PS3x | E12.0% | n/a | ||
ATGE | US$47.04 | 2.3% | 15.2% | US$1.8b | US$65.00 | PE15.1x | E33.3% | 0% | ||
GOTU | US$6.98 | 18.9% | 124.4% | US$1.8b | US$8.85 | PS4.4x | E83.6% | n/a | ||
UDMY | US$10.21 | 2.5% | 19.4% | US$1.6b | US$15.34 | PS2.1x | E43.0% | n/a | ||
AFYA | US$16.43 | 1.0% | 39.7% | US$1.5b | US$23.64 | PE19.6x | E34.4% | n/a |